These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23863691)

  • 21. Heat-Shock Protein 90-Targeted Nano Anticancer Therapy.
    Rochani AK; Ravindran Girija A; Borah A; Maekawa T; Sakthi Kumar D
    J Pharm Sci; 2016 Apr; 105(4):1454-66. PubMed ID: 26886301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganetespib and HSP90: translating preclinical hypotheses into clinical promise.
    Proia DA; Bates RC
    Cancer Res; 2014 Mar; 74(5):1294-300. PubMed ID: 24556722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsp90 inhibitors as promising agents for radiotherapy.
    Kabakov AE; Kudryavtsev VA; Gabai VL
    J Mol Med (Berl); 2010 Mar; 88(3):241-7. PubMed ID: 19946660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
    Lin SH; George TJ; Ben-Josef E; Bradley J; Choe KS; Edelman MJ; Guha C; Krishnan S; Lawrence TS; Le QT; Lu B; Mehta M; Peereboom D; Sarkaria J; Seong J; Wang D; Welliver MX; Coleman CN; Vikram B; Yoo S; Chung CH; ;
    J Natl Cancer Inst; 2013 May; 105(10):686-93. PubMed ID: 23503600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.
    Kelly CM; Buzdar AU
    Drugs; 2013 May; 73(6):505-15. PubMed ID: 23605692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitization in prostate cancer: mechanisms and targets.
    Palacios DA; Miyake M; Rosser CJ
    BMC Urol; 2013 Jan; 13():4. PubMed ID: 23351141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications.
    Bhat V; Pellizzari S; Allan AL; Wong E; Lock M; Brackstone M; Lohmann AE; Cescon DW; Parsyan A
    Crit Rev Oncol Hematol; 2022 Jan; 169():103566. PubMed ID: 34890802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosensitizing effect of cisplatin in prostate cancer cell lines.
    Geldof AA; Slotman BJ
    Cancer Lett; 1996 Mar; 101(2):233-9. PubMed ID: 8620475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.
    Schiewer MJ; Den R; Hoang DT; Augello MA; Lawrence YR; Dicker AP; Knudsen KE
    Endocr Relat Cancer; 2012 Feb; 19(1):1-12. PubMed ID: 21903859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.
    Vajda A; Marignol L; Foley R; Lynch TH; Lawler M; Hollywood D
    Cancer Treat Rev; 2011 Dec; 37(8):643-54. PubMed ID: 21481534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells.
    Lundsten S; Spiegelberg D; Stenerlöw B; Nestor M
    Int J Oncol; 2019 Dec; 55(6):1287-1295. PubMed ID: 31638190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targeted therapy in prevalent tumors: learning from the past and future perspectives.
    Metzger-Filho O; Moulin C; Awada A
    Curr Clin Pharmacol; 2010 Aug; 5(3):166-77. PubMed ID: 20406173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone.
    Yano A; Tsutsumi S; Soga S; Lee MJ; Trepel J; Osada H; Neckers L
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15541-6. PubMed ID: 18840695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
    Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
    Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
    Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC
    Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [FAK/c-Src signaling pathway mediates the expression of cell surface HSP90 in cultured human prostate cancer cells and its association with their invasive capability].
    Liu XG; Guo Y; Yan ZQ; Guo MY; Zhang ZG; Guo CA
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):340-4. PubMed ID: 21875461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.
    Narayan V; Vapiwala N; Mick R; Subramanian P; Christodouleas JP; Bekelman JE; Deville C; Rajendran R; Haas NB
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):355-361. PubMed ID: 27986349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective.
    Verheij M; Vens C; van Triest B
    Drug Resist Updat; 2010; 13(1-2):29-43. PubMed ID: 20167530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
    Dote H; Cerna D; Burgan WE; Camphausen K; Tofilon PJ
    Cancer Res; 2005 Aug; 65(15):6967-75. PubMed ID: 16061682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
    Austreid E; Lonning PE; Eikesdal HP
    Expert Opin Pharmacother; 2014 Apr; 15(5):681-700. PubMed ID: 24579888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.